Related references
Note: Only part of the references are listed.Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk
Thaddeus Judkins et al.
BMC CANCER (2015)
Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome
Matthew B. Yurgelun et al.
GASTROENTEROLOGY (2015)
Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population
Honglin Song et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Frequency of Mutations in Individuals With Breast Cancer Referred for BRCA1 and BRCA2 Testing Using Next-Generation Sequencing With a 25-Gene Panel
Nadine Tung et al.
CANCER (2015)
Evaluation of Clinical Criteria for the Identification of Lynch Syndrome among Unselected Patients with Endometrial Cancer
Amanda S. Bruegl et al.
CANCER PREVENTION RESEARCH (2014)
A comprehensive laboratory-based program for classification of variants of uncertain significance in hereditary cancer genes
J. M. Eggington et al.
CLINICAL GENETICS (2014)
Inversion of exons 1-7 of the MSH2 gene is a frequent cause of unexplained Lynch syndrome in one local population
Jennifer Rhees et al.
FAMILIAL CANCER (2014)
Colon and Endometrial Cancers With Mismatch Repair Deficiency Can Arise From Somatic, Rather Than Germline, Mutations
Sigurdis Haraldsdottir et al.
GASTROENTEROLOGY (2014)
Somatic aberrations of mismatch repair genes as a cause of microsatellite-unstable cancers
Willemina R. R. Geurts-Giele et al.
JOURNAL OF PATHOLOGY (2014)
BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma
Kathryn P. Pennington et al.
CANCER (2013)
Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts
Hans F. A. Vasen et al.
GUT (2013)
High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome
Virginie Bubien et al.
JOURNAL OF MEDICAL GENETICS (2013)
Cowden Syndrome and the PTEN Hamartoma Tumor Syndrome: Systematic Review and Revised Diagnostic Criteria
Robert Pilarski et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Evidence for Breast Cancer as an Integral Part of Lynch Syndrome
Nicole Buerki et al.
GENES CHROMOSOMES & CANCER (2012)
Prospective evaluation of molecular screening for Lynch syndrome in patients with endometrial cancer ≤70 years
Celine H. M. Leenen et al.
GYNECOLOGIC ONCOLOGY (2012)
Germline RAD51C mutations confer susceptibility to ovarian cancer
Chey Loveday et al.
NATURE GENETICS (2012)
Lynch Syndrome
Floor J. Backes et al.
CLINICAL OBSTETRICS AND GYNECOLOGY (2011)
Germline mutations in RAD51D confer susceptibility to ovarian cancer
Chey Loveday et al.
NATURE GENETICS (2011)
Mutations in BRIP1 confer high risk of ovarian cancer
Thorunn Rafnar et al.
NATURE GENETICS (2011)
Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing
Tom Walsh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Risks of Lynch Syndrome Cancers for MSH6 Mutation Carriers
Laura Baglietto et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Calculation of Risk of Colorectal and Endometrial Cancer Among Patients With Lynch Syndrome
Elena Stoffel et al.
GASTROENTEROLOGY (2009)
ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007
C. Sue Richards et al.
GENETICS IN MEDICINE (2008)
Carcinoma of the Lower Uterine Segment: A Newly Described Association With Lynch Syndrome
Shannon N. Westin et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer
Karen H. Lu et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Society of Gynecologic Oncologists education committee statement on risk assessment for inherited gynecologic cancer predispositions
Johnathan M. Lancaster et al.
GYNECOLOGIC ONCOLOGY (2007)
Cancer risks among BRCA1 and BRCA2 mutation carriers
E. Levy-Lahad et al.
BRITISH JOURNAL OF CANCER (2007)
High incidence of BRCA1-2 germline mutations, previous breast cancer and familial cancer history in Jewish patients with uterine serous papillary carcinoma
T. Biron-Shental et al.
EJSO (2006)
Hereditary cancer predisposition syndromes
JE Garber et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
CHEK2 is a multiorgan cancer susceptibility gene
C Cybulski et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations:: Impact on counseling and surveillance
YMC Hendriks et al.
GASTROENTEROLOGY (2004)
Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2
MC King et al.
SCIENCE (2003)
The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype
H Meijers-Heijboer et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies
A Antoniou et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Mutations in CHEK2 associated with prostate cancer risk
XY Dong et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations
H Meijers-Heijboer et al.
NATURE GENETICS (2002)
Risk of endometrial carcinoma associated with BRCA mutation
DA Levine et al.
GYNECOLOGIC ONCOLOGY (2001)
Is uterine papillary serous adenocarcinoma a manifestation of the hereditary breast-ovarian cancer syndrome?
R Goshen et al.
GYNECOLOGIC ONCOLOGY (2000)
Share Paper
